scholarly article | Q13442814 |
P50 | author | Malik Peiris | Q6743602 |
Yuen Kwok-yung | Q8060280 | ||
P2093 | author name string | Yuen KY | |
Seto WH | |||
Chan KH | |||
Yam WC | |||
Poon LL | |||
Guan Y | |||
P2860 | cites work | Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 |
Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 | ||
Identification of a novel coronavirus in patients with severe acute respiratory syndrome | Q29615907 | ||
The Genome sequence of the SARS-associated coronavirus | Q29619007 | ||
A major outbreak of severe acute respiratory syndrome in Hong Kong | Q33347382 | ||
Evaluation of the Directigen FluA+B test for rapid diagnosis of influenza virus type A and B infections | Q34193342 | ||
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong | Q34202150 | ||
A cluster of cases of severe acute respiratory syndrome in Hong Kong. | Q37869740 | ||
Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. | Q39552353 | ||
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study | Q40557821 | ||
Direct diagnosis of human respiratory coronaviruses 229E and OC43 by the polymerase chain reaction | Q40788879 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | severe acute respiratory syndrome | Q103177 |
Coronaviridae | Q1134583 | ||
P304 | page(s) | 4521-4524 | |
P577 | publication date | 2003-10-01 | |
P1433 | published in | Journal of Clinical Microbiology | Q4041880 |
P1476 | title | Evaluation of reverse transcription-PCR assays for rapid diagnosis of severe acute respiratory syndrome associated with a novel coronavirus | |
P478 | volume | 41 |
Q38149466 | A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications |
Q46651577 | Amotosalen photochemical inactivation of severe acute respiratory syndrome coronavirus in human platelet concentrates |
Q33316491 | Application of ProteinChip array profiling in serum biomarker discovery for patients suffering from severe acute respiratory syndrome |
Q97529850 | COVID-19 diagnostic approaches: different roads to the same destination |
Q47697594 | Clinical and molecular epidemiological features of coronavirus HKU1-associated community-acquired pneumonia |
Q40434683 | Clinical evaluation of real-time PCR assays for rapid diagnosis of SARS coronavirus during outbreak and post-epidemic periods |
Q33363623 | Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children |
Q40429766 | Comparative host gene transcription by microarray analysis early after infection of the Huh7 cell line by severe acute respiratory syndrome coronavirus and human coronavirus 229E. |
Q44531274 | Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods |
Q51636846 | Crouching tiger, hidden dragon: the laboratory diagnosis of severe acute respiratory syndrome. |
Q36988822 | Currently used nucleic acid amplification tests for the detection of viruses and atypicals in acute respiratory infections |
Q90668458 | Detection and analysis system for hybridization images of lab-in-a-tube microarray |
Q54504477 | Detection of SARS coronavirus in humans and animals by conventional and quantitative (real time) reverse transcription polymerase chain reactions. |
Q24600052 | Detection of SARS coronavirus in patients with suspected SARS |
Q84364055 | Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor |
Q41067281 | Detection of severe acute respiratory syndrome coronavirus in stool specimens by commercially available real-time reverse transcriptase PCR assays. |
Q40834199 | Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia. |
Q33988693 | Detection of the nucleocapsid protein of severe acute respiratory syndrome coronavirus in serum: comparison with results of other viral markers. |
Q33859082 | Development and evaluation of a multitarget real-time Taqman reverse transcription-PCR assay for detection of the severe acute respiratory syndrome-associated coronavirus and surveillance for an apparently related coronavirus found in masked palm ci |
Q33715186 | Development and evaluation of a novel loop-mediated isothermal amplification method for rapid detection of severe acute respiratory syndrome coronavirus |
Q44985460 | Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein |
Q42551513 | Diagnostic criteria during SARS outbreak in Hong Kong. |
Q39652368 | Diagnostics of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid antigen using chicken immunoglobulin Y. |
Q41828714 | Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. |
Q35718659 | Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. |
Q80483273 | Emerging viral infections |
Q41005384 | Evaluation and validation of an enzyme-linked immunosorbent assay and an immunochromatographic test for serological diagnosis of severe acute respiratory syndrome |
Q33714617 | Evaluation of advanced reverse transcription-PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus |
Q33212372 | Identification of single-chain antibody fragments specific against SARS-associated coronavirus from phage-displayed antibody library |
Q33859071 | Immunofluorescence assay for detection of the nucleocapsid antigen of the severe acute respiratory syndrome (SARS)-associated coronavirus in cells derived from throat wash samples of patients with SARS. |
Q46954531 | Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents |
Q30354157 | Influenza and endemic viral pneumonia. |
Q51878023 | Intrahost diversity of feline coronavirus: a consensus between the circulating virulent/avirulent strains and the internal mutation hypotheses? |
Q30223960 | Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? |
Q39134260 | Isolation and genetic characterization of human coronavirus NL63 in primary human renal proximal tubular epithelial cells obtained from a commercial supplier, and confirmation of its replication in two different types of human primary kidney cells |
Q24675259 | Laboratory diagnosis of SARS |
Q35880624 | Laboratory diagnosis of SARS. |
Q94602569 | Making waves: Coronavirus detection, presence and persistence in the water environment: State of the art and knowledge needs for public health |
Q33266069 | Microarray-in-a-tube for detection of multiple viruses |
Q35998116 | Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV). |
Q87748572 | Molecular immune pathogenesis and diagnosis of COVID-19 |
Q37183997 | Molecular targets for diagnostics and therapeutics of severe acute respiratory syndrome (SARS-CoV). |
Q40773071 | Monoclonal antibody-based antigen capture enzyme-linked immunosorbent assay reveals high sensitivity of the nucleocapsid protein in acute-phase sera of severe acute respiratory syndrome patients |
Q28385241 | Neutralizing antibody response and SARS severity |
Q30233119 | Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. |
Q33858802 | Novel immunofluorescence assay using recombinant nucleocapsid-spike fusion protein as antigen to detect antibodies against severe acute respiratory syndrome coronavirus |
Q42541076 | Nucleocapsid protein as early diagnostic marker for SARS. |
Q28364965 | Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study |
Q38610308 | Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein. |
Q36600036 | Preclinical evaluation of two real-time, reverse transcription-PCR assays for detection of the severe acute respiratory syndrome coronavirus |
Q33206775 | Protein chip array profiling analysis in patients with severe acute respiratory syndrome identified serum amyloid a protein as a biomarker potentially useful in monitoring the extent of pneumonia |
Q33859156 | Rapid and sensitive detection of severe acute respiratory syndrome coronavirus by rolling circle amplification |
Q28279368 | Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR |
Q35879781 | Real-time polymerase chain reaction for detecting SARS coronavirus, Beijing, 2003 |
Q34306956 | Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus |
Q40685865 | Recombinant protein-based enzyme-linked immunosorbent assay and immunochromatographic tests for detection of immunoglobulin G antibodies to severe acute respiratory syndrome (SARS) coronavirus in SARS patients. |
Q40558276 | Reverse transcriptase PCR diagnostic assay for the coronavirus associated with severe acute respiratory syndrome. |
Q44503708 | Risk of transmission of severe acute respiratory syndrome to household contacts by infected health care workers and patients. |
Q36622031 | SARS and other coronaviruses in humans and animals |
Q35872905 | SARS antibody test for serosurveillance |
Q37524036 | SARS vaccines: where are we? |
Q36009490 | SARS-CoV infection in a restaurant from palm civet |
Q97530999 | SARS-CoV-2 prevalence in an asymptomatic cancer cohort - results and consequences for clinical routine |
Q36423694 | Sensitive and specific enzyme-linked immunosorbent assay using chemiluminescence for detection of severe acute respiratory syndrome viral infection |
Q40938343 | Sensitive and specific monoclonal antibody-based capture enzyme immunoassay for detection of nucleocapsid antigen in sera from patients with severe acute respiratory syndrome. |
Q33223139 | Sensitive detection of SARS coronavirus RNA by a novel asymmetric multiplex nested RT-PCR amplification coupled with oligonucleotide microarray hybridization |
Q30210679 | Serological assays for emerging coronaviruses: challenges and pitfalls |
Q91907727 | Severe acute respiratory syndrome (SARS) in intensive care units (ICUs): limiting the risk to healthcare workers |
Q28383088 | Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection |
Q30340986 | Severe acute respiratory syndrome: a singular epidemic of viral pneumonia |
Q90735399 | Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19) |
Q90722842 | Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19) |
Q91909018 | Síndrome respiratorio agudo grave |
Q35937519 | The aetiology, origins, and diagnosis of severe acute respiratory syndrome. |
Q47774801 | The probability of failing in detecting an infectious disease at entry points into a country |
Q44615750 | The use of proteomics in the discovery of serum biomarkers from patients with severe acute respiratory syndrome. |
Q37595195 | Use of viral lysate antigen combined with recombinant protein in Western immunoblot assay as confirmatory test for serodiagnosis of severe acute respiratory syndrome |
Q42096754 | Using patient-collected clinical samples and sera to detect and quantify the severe acute respiratory syndrome coronavirus (SARS-CoV). |
Q94672349 | Validation of SARS-CoV-2 detection across multiple specimen types |
Q35872810 | Viral loads in clinical specimens and SARS manifestations. |
Q42984516 | Viral vaccine meeting held in Barcelona, October 25-28, 2003. |
Search more.